Quotient Therapeutics
Discover how Quotient is pioneering a new field of genetics with somatic genomics to unveil a universe of genetic information and develop new therapies.
$50M Series B+ ·
Led by Flagship Pioneering · Source: fundraisingfox.com
Funding history ↓Signals
Quotient Therapeutics | 183 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $50M | fundraisingfox.com |
Timeline
- X account created
- Website created
Founders and team
GV
Geoffrey von Maltzahn FounderPC
Peter Campbell CSO & Academic CofounderLinkedIn · source: quotient-tx.comRK
Rahul Kakkar President and Chief Executive OfficerSK
Susan Keefe Chief Financial Officer
Investors
Companies like Quotient Therapeutics
CColossal$120M Series B+ · Sep 2025
CCodebreaker Labs$5.88M Seed · Aug 2026
JJungla
CCrossbow Therapeutics$77M Series B+ · Mar 2026
EElement Biosciences$175M Series B+ · Jun 2026
VVico Therapeutics$71M Series B+ · Jun 2024
Other companies backed by Flagship Pioneering
AAmpersand Biomedicines$65M Series B+ · Mar 2025
AApriori Bio$1.1M · Jul 2024
PPrologue Medicines$50M · May 2024
HHarbinger HealthSeries B+ · Apr 2026
CCellaritySeries B+ · Nov 2024
Flagship Pioneering portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/quotient-therapeutics (get a free API key).